Clinical Trial Update: CAR-T Cell Immunotherapy for Advanced Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of CAR-T cell immunotherapy in advanced lung cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced Lung Cancer | Phase 1 | Status: TERMINATED | Results posted: 2020-07-13